Compare EQH & ELAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | EQH | ELAN |
|---|---|---|
| Founded | 1859 | 1954 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Specialty Insurers | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 14.7B | 12.2B |
| IPO Year | 2017 | 2018 |
| Metric | EQH | ELAN |
|---|---|---|
| Price | $55.86 | $24.68 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 12 | 16 |
| Target Price | ★ $64.00 | $30.23 |
| AVG Volume (30 Days) | 2.5M | ★ 4.5M |
| Earning Date | 11-02-2026 | 11-06-2026 |
| Dividend Yield | ★ 2.21% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.50 | 0.22 |
| Revenue | ★ $11,665,000,000.00 | $4,715,000,000.00 |
| Revenue This Year | $33.22 | $8.80 |
| Revenue Next Year | $10.30 | $5.39 |
| P/E Ratio | $108.77 | ★ $108.43 |
| Revenue Growth | N/A | ★ 6.22 |
| 52 Week Low | $35.20 | $19.40 |
| 52 Week High | $55.67 | $27.98 |
| Indicator | EQH | ELAN |
|---|---|---|
| Relative Strength Index (RSI) | 60.95 | 64.67 |
| Support Level | $50.30 | $23.40 |
| Resistance Level | N/A | $24.27 |
| Average True Range (ATR) | 1.67 | 0.67 |
| MACD | 0.07 | 0.17 |
| Stochastic Oscillator | 93.46 | 97.60 |
Equitable Holdings Inc is a financial services company providing retirement, asset management, and wealth management solutions for individual and institutional clients, operating through three segments. The Retirement segment generates the majority of revenue and offers annuities, retirement savings plans, institutional savings products, and includes the spread lending business. The Asset Management segment provides diversified investment management and related services globally through Institutional, Retail, and Private Wealth channels and reflects the business of AB. The Wealth Management segment offers advisory accounts, financial planning and advice, life insurance, and annuity products. Revenues are earned predominantly from fee income, income from investments, and insurance premiums.
Elanco Animal Health is an animal health company that is engaged in developing, manufacturing, and marketing pharma products for companion and food animals. It spun off from Eli Lilly in 2018 and acquired Janssen Animal Health in 2011, Novartis Animal Health in 2014, Boehringer Ingelheim Vetmedica in 2017, and Bayer Animal Health in 2020. The company's operations are conducted globally, and it sells its products in over 90 countries. It offers a range of food animal products used in cattle, sheep, poultry, and swine production.